Literature DB >> 26052382

Non-alcoholic fatty liver disease - the heart of the matter.

Haneen Azzam1, Stephen Malnick1.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is one of the most common forms of chronic liver disease in the Western world. There is a close association with the metabolic syndrome and NAFLD is considered to be the hepatic manifestation of the metabolic syndrome. The components of the metabolic syndrome include hypertension, obesity and insulin resistance which are well established cardiovascular risk factors. The mortality rate of NAFLD patients from myocardial infarction is higher than that in the general United States population and there is also an increased risk of non-fatal cardiovascular events. This article reviews the cardiovascular complications associated with NAFLD. In order to provide comprehensive care of NAFLD patients, physicians need to be aware of, and search for, the cardiac morbidity associated with NAFLD.

Entities:  

Keywords:  Cardiovascular; Diastolic dysfunction; Non-alcoholic fatty liver disease; Palatin-like phospholipase domain containing 3 gene; Sleep apnea

Year:  2015        PMID: 26052382      PMCID: PMC4450200          DOI: 10.4254/wjh.v7.i10.1369

Source DB:  PubMed          Journal:  World J Hepatol


  67 in total

1.  Hypoxic hepatitis caused by severe hypoxemia from obstructive sleep apnea.

Authors:  J Henrion; L Colin; M Schapira; F R Heller
Journal:  J Clin Gastroenterol       Date:  1997-06       Impact factor: 3.062

Review 2.  Nonalcoholic fatty liver disease.

Authors:  Leon A Adams; Keith D Lindor
Journal:  Ann Epidemiol       Date:  2007-08-28       Impact factor: 3.797

3.  Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients.

Authors:  Giovanni Targher; Lorenzo Bertolini; Felice Poli; Stefano Rodella; Luca Scala; Roberto Tessari; Luciano Zenari; Giancarlo Falezza
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

4.  Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study.

Authors:  Roger K Schindhelm; Jacqueline M Dekker; Giel Nijpels; Lex M Bouter; Coen D A Stehouwer; Robert J Heine; Michaela Diamant
Journal:  Atherosclerosis       Date:  2006-05-08       Impact factor: 5.162

Review 5.  Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome.

Authors:  Luciano F Drager; Sônia M Togeiro; Vsevolod Y Polotsky; Geraldo Lorenzi-Filho
Journal:  J Am Coll Cardiol       Date:  2013-06-12       Impact factor: 24.094

6.  Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

Authors:  Masahide Hamaguchi; Takao Kojima; Noriyuki Takeda; Chisato Nagata; Jun Takeda; Hiroshi Sarui; Yutaka Kawahito; Naohisa Yoshida; Atsushi Suetsugu; Takahiro Kato; Junichi Okuda; Kazunori Ida; Toshikazu Yoshikawa
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

7.  Insulin resistance and sleep-disordered breathing in healthy humans.

Authors:  R A Stoohs; F Facchini; C Guilleminault
Journal:  Am J Respir Crit Care Med       Date:  1996-07       Impact factor: 21.405

8.  The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects.

Authors:  Ki Chul Sung; Marno C Ryan; Andrew M Wilson
Journal:  Atherosclerosis       Date:  2008-07-31       Impact factor: 5.162

9.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

10.  Pathophysiologic mechanisms of cardiovascular disease in obstructive sleep apnea syndrome.

Authors:  Carlos Zamarrón; Luis Valdés Cuadrado; Rodolfo Alvarez-Sala
Journal:  Pulm Med       Date:  2013-06-27
View more
  13 in total

1.  Associations of TM6SF2 167K allele with liver enzymes and lipid profile in children: the PANIC Study.

Authors:  Anna Viitasalo; Jussi Pihlajamäki; Jussi Paananen; Mustafa Atalay; Virpi Lindi; Timo A Lakka
Journal:  Pediatr Res       Date:  2016-01-12       Impact factor: 3.756

Review 2.  Naturally Occurring Nrf2 Activators: Potential in Treatment of Liver Injury.

Authors:  Ravirajsinh N Jadeja; Kapil K Upadhyay; Ranjitsinh V Devkar; Sandeep Khurana
Journal:  Oxid Med Cell Longev       Date:  2016-12-22       Impact factor: 6.543

3.  Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study.

Authors:  Adeyinka Charles Adejumo; Samson Alliu; Tokunbo Opeyemi Ajayi; Kelechi Lauretta Adejumo; Oluwole Muyiwa Adegbala; Nnaemeka Egbuna Onyeakusi; Akintunde Micheal Akinjero; Modupeoluwa Durojaiye; Terence Ndonyi Bukong
Journal:  PLoS One       Date:  2017-04-25       Impact factor: 3.240

Review 4.  Antioxidant dietary approach in treatment of fatty liver: New insights and updates.

Authors:  Alessandra Ferramosca; Mariangela Di Giacomo; Vincenzo Zara
Journal:  World J Gastroenterol       Date:  2017-06-21       Impact factor: 5.742

Review 5.  Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis-Literature Review.

Authors:  Abdulrahman Ismaiel; Dan L Dumitraşcu
Journal:  Front Med (Lausanne)       Date:  2019-09-13

6.  Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus.

Authors:  Hokyou Lee; Gyuri Kim; Young Ju Choi; Byung Wook Huh; Byung Wan Lee; Eun Seok Kang; Bong Soo Cha; Eun Jig Lee; Yong Ho Lee; Kap Bum Huh
Journal:  Diabetes Metab J       Date:  2019-02-28       Impact factor: 5.376

7.  Association between the liver fat score (LFS) and cardiovascular diseases in the national health and nutrition examination survey 1999-2016.

Authors:  Chun-On Lee; Hang-Long Li; Man-Fung Tsoi; Ching-Lung Cheung; Bernard Man Yung Cheung
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

8.  Vitamin B6 Prevents Endothelial Dysfunction, Insulin Resistance, and Hepatic Lipid Accumulation in Apoe (-/-) Mice Fed with High-Fat Diet.

Authors:  Zhan Liu; Peng Li; Zhi-Hong Zhao; Yu Zhang; Zhi-Min Ma; Shuang-Xi Wang
Journal:  J Diabetes Res       Date:  2015-12-31       Impact factor: 4.011

9.  Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study.

Authors:  Hyeok-Hee Lee; Yongin Cho; Young Ju Choi; Byung Wook Huh; Byung-Wan Lee; Eun Seok Kang; Seok Won Park; Bong-Soo Cha; Eun Jig Lee; Yong-Ho Lee; Kap Bum Huh
Journal:  Cardiovasc Diabetol       Date:  2020-06-13       Impact factor: 9.951

Review 10.  NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome.

Authors:  Valerio Rosato; Mario Masarone; Marcello Dallio; Alessandro Federico; Andrea Aglitti; Marcello Persico
Journal:  Int J Environ Res Public Health       Date:  2019-09-14       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.